Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,854 GBX | +2.26% | +3.63% | +3.63% |
Apr. 25 | Hikma Pharmaceuticals backs outlook after making strong start to 2024 | AN |
Apr. 25 | Hikma Pharmaceuticals Affirms FY24 Guidance | MT |
ETFs positioned on Hikma Pharmaceuticals PLC
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 1,120 M€ | -0.07% | ||
0.25% | 3 M€ | +9.95% | - | |
0.20% | 11 M€ | +0.83% | - | |
0.16% | 18 M€ | +3.97% | - | |
0.15% | 5 M€ | +10.09% | - | |
0.15% | 14 M€ | +5.66% | - | |
0.04% | 6 M€ | -.--% | ||
0.02% | 10 M€ | -3.35% | - | |
0.01% | 31 M€ | +2.71% | - | |
0.01% | 284 M€ | -.--% | ||
0.01% | 206 M€ | -.--% | ||
0.01% | 1,166 M€ | +0.26% | - | |
0.01% | 607 M€ | +0.05% | - | |
0.01% | 23 M€ | -.--% | - | |
0.01% | 786 M€ | -.--% | ||
0.01% | 273 M€ | +15.83% | ||
0.00% | 389 M€ | +4.94% | - | |
0.00% | 34 M€ | +2.22% | - | |
0.00% | 7 M€ | +0.11% | - | |
0.00% | 34 M€ | +5.94% | - | |
0.00% | 237 M€ | +1.04% | - | |
0.00% | 302 M€ | +2.88% | - | |
0.00% | 39 M€ | +2.96% | - | |
0.00% | 26 M€ | 0.00% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.63% | 5.14B | |
+24.17% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+6.04% | 201B | |
-10.51% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- HIK Stock
- Funds and ETFs Hikma Pharmaceuticals PLC